Rossby Financial’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.35K Sell
117
-64
-35% -$3.8K ﹤0.01% 1799
2026
Q2
$10.9K Hold
181
– – ﹤0.01% 1152
2026
Q1
$10.3K Buy
181
+134
+285% +$6.17K ﹤0.01% 1241
2025
Q4
$2.11K Buy
47
+7
+18% +$294 ﹤0.01% 1356
2025
Q3
$1.56K Buy
+40
New +$1.41K ﹤0.01% 1198

Other funds holding XENE

Rossby Financial's XENE Position: Q3 2026 in Review

Rossby Financial reduced its Xenon Pharmaceuticals (XENE) stake by 35% in Q3 2026, selling an estimated $3.8K and leaving 117 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #1799.

Rossby Financial first reported a position in XENE in Q3 2025 and has held it in 5 quarters since. The position peaked at $10.9K in Q2 2026. 286 funds tracked by Wall St. Rank hold XENE as of Q3 2026.

  • Rossby Financial held 117 shares of Xenon Pharmaceuticals worth $4.35K as of Q3 2026.
  • Rossby Financial sold 64 Xenon Pharmaceuticals shares in Q3 2026, an estimated $3.8K.
  • Xenon Pharmaceuticals made up ﹤0.01% of Rossby Financial's portfolio in Q3 2026, its #1799 holding.
  • Rossby Financial first reported a position in Xenon Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Rossby Financial's Xenon Pharmaceuticals position peaked at $10.9K in Q2 2026.
  • 286 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.

Based on Rossby Financial's 13F filing for Q3 2026, filed 5 Nov 2026.